Document is current

Article History

Received: 27 March 2026

Accepted: 10 May 2026

First Online: 29 June 2026

Declarations

Funding: This work was supported by Friedreich ataxia Research Alliance grants to DRL, and the US Department of Defense grants (USAMRAA) HT94252510542 (DRL).

Conflict of interest: Michael Lazaropoulos declares that he has no conflicts of interest that might be relevant to the contents of this manuscript. Dr Lynch receives grants to perform clinical trials for Solid, Larimar, Biogen, and PTC, and has previously received grants from Neurocrine and Design.

Ethics approval: Not applicable.

Consent: Not applicable.

Authors’ contributions: MPL and DRL are responsible for the conceptualization, writing, and editing of the text and figures of this article. All authors have read and approved the final version.

Data availability: Not applicable.

Code availability: Not applicable.